Sandra Kunz

Papers

Total Citations

H-Index

About

Sandra Kunz is a rising leader in the field of precision bioengineering, with a core focus on developing automated systems for high-throughput biological assays. Her primary research centers on the intersection of robotics, microfluidics, and cancer biology, specifically targeting the automation of complex in vivo models. Kunz’s most significant contribution is her pioneering work on automated microinjection for zebrafish xenograft models. By engineering a system to precisely and rapidly inject cancer cells into fragile zebrafish larvae, she has addressed a critical bottleneck in translating these models from research tools to clinical diagnostics. This innovation dramatically reduces the labor and variability associated with manual injection, making it feasible to use zebrafish for personalized cancer therapy screening. While her work is still emerging, with her most cited paper (2025) garnering 5 citations, its potential impact is substantial. Kunz is recognized for bridging engineering and oncology, and her automated platform is poised to accelerate drug discovery and enable patient-specific treatment predictions, marking her as a key innovator in next-generation diagnostic tools.